BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 7769429)

  • 1. Myocardial technetium-99m-teboroxime activity in acute coronary artery occlusion and reperfusion: relation to myocardial blood flow and viability.
    Abraham SA; Mirecki FN; Levine D; Nunn AD; Strauss HW; Gewirtz H
    J Nucl Med; 1995 Jun; 36(6):1062-8. PubMed ID: 7769429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of 99mTc-teboroxime with thallium for myocardial imaging in the presence of a coronary artery stenosis.
    Gray WA; Gewirtz H
    Circulation; 1991 Oct; 84(4):1796-807. PubMed ID: 1914115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of sequential teboroxime imaging for the detection of coronary artery occlusion and reperfusion in ischemic and infarcted myocardium.
    Heller LI; Villegas BJ; Weiner BH; McSherry BA; Dahlberg ST; Leppo JA
    Am Heart J; 1994 Apr; 127(4 Pt 1):779-85. PubMed ID: 8154415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 99mTc-tetrofosmin assessment of myocardial perfusion and viability in canine models of coronary occlusion and reperfusion.
    Glover DK; Ruiz M; Koplan BA; Watson DD; Beller GA
    J Nucl Med; 1999 Jan; 40(1):142-9. PubMed ID: 9935070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial technetium-99m-teboroxime uptake during adenosine-induced hyperemia in dogs with either a critical or mild coronary stenosis: comparison to thallium-201 and regional blood flow.
    Glover DK; Ruiz M; Bergmann EE; Simanis JP; Smith WH; Watson DD; Beller GA
    J Nucl Med; 1995 Mar; 36(3):476-83. PubMed ID: 7884514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial kinetics of technetium-99m teboroxime in the presence of postischemic injury, necrosis and low flow reperfusion.
    Beanlands RS; DeKemp RA; Harmsen E; Veinot JP; Hartman NG; Ruddy TD
    J Am Coll Cardiol; 1996 Aug; 28(2):487-94. PubMed ID: 8800130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between myocardial retention of technetium-99m teboroxime and myocardial blood flow.
    Beanlands R; Muzik O; Nguyen N; Petry N; Schwaiger M
    J Am Coll Cardiol; 1992 Sep; 20(3):712-9. PubMed ID: 1512353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of collateral flow and myocardial viability on the distribution of technetium-99m sestamibi in a closed-chest model of coronary occlusion and reperfusion.
    Chareonthaitawee P; O'Connor MK; Gibbons RJ; Ritman EL; Christian TF
    Eur J Nucl Med; 2000 May; 27(5):508-16. PubMed ID: 10853805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teboroxime is a marker of reperfusion after myocardial infarction.
    Heller LI; Villegas BJ; Reinhardt CP; Dahlberg ST; Marcel R; Leppo JA
    J Nucl Cardiol; 1996; 3(1):2-8. PubMed ID: 8799222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of technetium-99m-teboroxime in reperfused nonviable myocardium.
    Okada RD; Glover DK; Moffett JD; Beju D; Johnson G
    J Nucl Med; 1997 Feb; 38(2):274-9. PubMed ID: 9025755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial accumulation and clearance of technetium 99m teboroxime at 100%, 75%, 50% and zero coronary blood flow in dogs.
    Pieri P; Yasuda T; Fischman AJ; Ahmad M; Moore R; Yaoita H; Strauss HW
    Eur J Nucl Med; 1991; 18(9):725-31. PubMed ID: 1936048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early detection of infarct in reperfused canine myocardium using 99mTc-glucarate.
    Okada DR; Johnson G; Liu Z; Hocherman SD; Khaw BA; Okada RD
    J Nucl Med; 2004 Apr; 45(4):655-64. PubMed ID: 15073263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technetium 99m-HL-91: a potential new marker of myocardial viability assessed by nuclear imaging early after reperfusion.
    Johnson G; Nguyen KN; Liu Z; Okada RD
    J Nucl Cardiol; 1998; 5(3):285-94. PubMed ID: 9669583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tc-99m sestamibi defect magnitude predicts the amount of viable myocardium after coronary reperfusion despite the presence of severe residual stenosis.
    Takehana K; Ruiz M; Petruzella FD; Watson DD; Beller GA; Glover DK
    J Nucl Cardiol; 2001; 8(1):40-8. PubMed ID: 11182708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 99mTc-sestamibi uptake and retention during myocardial ischemia and reperfusion.
    Beller GA; Glover DK; Edwards NC; Ruiz M; Simanis JP; Watson DD
    Circulation; 1993 Jun; 87(6):2033-42. PubMed ID: 8504518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations between uptake of technetium-99m Q12 and thallium-201: myocardial perfusion and viability in a model of acute coronary reperfusion.
    Takahashi N; Reinhardt CP; Marcel R; Leppo JA
    J Nucl Med; 1998 Jan; 39(1):159-65. PubMed ID: 9443756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial clearance of technetium-99m-teboroxime in reperfused injured canine myocardium.
    Okada DR; Johnson G; Okada RD
    EJNMMI Res; 2014; 4():42. PubMed ID: 25411652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of residual coronary stenoses using 99mTc-N-NOET vasodilator stress imaging to evaluate coronary flow reserve early after coronary reperfusion in a canine model of subendocardial infarction.
    Takehana K; Beller GA; Ruiz M; Petruzella FD; Watson DD; Glover DK
    J Nucl Med; 2001 Sep; 42(9):1388-94. PubMed ID: 11535730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial uptake of a (99m)Tc-nitroheterocycle in a swine model of occlusion and reperfusion.
    Johnson LL; Schofield L; Donahay T; Mastrofrancesco P
    J Nucl Med; 2000 Jul; 41(7):1237-43. PubMed ID: 10914916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (99m)Tc-glucarate imaging for the early detection of infarct in partially reperfused canine myocardium.
    Johnson G; Okada CC; Hocherman SD; Liu Z; Hart C; Khaw BA; Okada RD
    Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):319-28. PubMed ID: 16237571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.